IL1B and colitis: This suggests that, consistent with the pro-inflammatory role of NLRP3 and IL-1β in intestinal inflammation, the E. faecalis pretreatment-induced attenuation of NLRP3 inflammasome activity in macrophages can ameliorate DSS-induced colitis.